XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Deficit - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Noncontrolling Interests in Subsidiaries
Beginning balance (in shares) at Dec. 27, 2020   32,545          
Beginning balance at Dec. 27, 2020 $ (266,939) $ 453 $ 254,103 $ (14,168) $ 219,158 $ (741,724) $ 15,239
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [1] 97,222       95,393   1,829
Other comprehensive (loss) income, net of tax 4,258     4,258      
Repurchase and conversion of Series B Convertible Preferred Stock (in shares)   3,489          
Repurchase and conversion of Series B Convertible Preferred Stock 64,168 $ 35 174,631   (110,498)    
Cash dividends on common stock (27,640)   110   (27,750)    
Cash dividends on preferred stock (4,121)       (4,121)    
Exercise of stock options (in shares)   199          
Exercise of stock options 11,211 $ 2 11,209        
Acquisition of Company common stock (in shares)   (187)          
Acquisition of Company common stock (20,555)         (20,555)  
Stock-based compensation expense 12,519   12,519        
Issuance of restricted stock (in shares)   125          
Issuance of restricted stock 0   (6,538)     6,538  
Tax payments for equity award issuances (5,310)   (5,310)        
Distributions to noncontrolling interests (1,779)           (1,779)
Other (in shares)   12          
Other (80)   18   (804) 706  
Ending balance (in shares) at Sep. 26, 2021   36,183          
Ending balance at Sep. 26, 2021 (137,046) $ 490 440,742 (9,910) 171,378 (755,035) 15,289
Beginning balance (in shares) at Jun. 27, 2021   36,215          
Beginning balance at Jun. 27, 2021 (147,898) $ 489 435,608 (10,235) 154,769 (743,819) 15,290
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [1] 29,849       29,256   593
Other comprehensive (loss) income, net of tax 325     325      
Cash dividends on common stock (12,797)   48   (12,845)    
Exercise of stock options (in shares)   51          
Exercise of stock options 3,112 $ 1 3,111        
Acquisition of Company common stock (in shares)   (103)          
Acquisition of Company common stock (12,367)         (12,367)  
Stock-based compensation expense 4,317   4,317        
Issuance of restricted stock (in shares)   15          
Issuance of restricted stock 0   (873)     873  
Tax payments for equity award issuances (1,423)   (1,423)        
Distributions to noncontrolling interests (594)           (594)
Other (in shares)   5          
Other 430   (46)   198 278  
Ending balance (in shares) at Sep. 26, 2021   36,183          
Ending balance at Sep. 26, 2021 $ (137,046) $ 490 440,742 (9,910) 171,378 (755,035) 15,289
Beginning balance (in shares) at Dec. 26, 2021 35,800 35,797          
Beginning balance at Dec. 26, 2021 $ (172,458) $ 490 445,126 (9,971) 183,157 (806,472) 15,212
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [2] 45,062       44,258   804
Other comprehensive (loss) income, net of tax (3,897)     (3,897)      
Cash dividends on common stock (39,949)   153   (40,102)    
Exercise of stock options (in shares)   55          
Exercise of stock options 2,731   2,730        
Acquisition of Company common stock (in shares)   (982)          
Acquisition of Company common stock (95,000)         (95,000)  
Stock-based compensation expense 14,246 $ 0 14,246        
Issuance of restricted stock (in shares)   279          
Issuance of restricted stock 88   (8,122)     8,210  
Tax payments for equity award issuances (in shares)   (92)          
Tax payments for equity award issuances (9,426)   (9,426)        
Distributions to noncontrolling interests (366)           (366)
Other (in shares)   8          
Other $ 350   (64)   (27) 444 (3)
Ending balance (in shares) at Sep. 25, 2022 35,100 35,065          
Ending balance at Sep. 25, 2022 $ (258,619) $ 491 444,643 (13,868) 187,286 (892,818) 15,647
Beginning balance (in shares) at Jun. 26, 2022   35,248          
Beginning balance at Jun. 26, 2022 (233,798) $ 491 442,255 (11,034) 193,934 (875,205) 15,761
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [2] 8,433       8,331   102
Other comprehensive (loss) income, net of tax (2,834)     (2,834)      
Cash dividends on common stock (14,849)   57   (14,906)    
Exercise of stock options (in shares)   16          
Exercise of stock options 823   823        
Acquisition of Company common stock (in shares)   (229)          
Acquisition of Company common stock (19,529)         (19,529)  
Stock-based compensation expense 5,146   5,146        
Issuance of restricted stock (in shares)   50          
Issuance of restricted stock 89   (1,671)     1,760  
Tax payments for equity award issuances (in shares)   (22)          
Tax payments for equity award issuances (1,900)   (1,900)        
Distributions to noncontrolling interests (216)           (216)
Other (in shares)   2          
Other $ 16   (67)   (73) 156  
Ending balance (in shares) at Sep. 25, 2022 35,100 35,065          
Ending balance at Sep. 25, 2022 $ (258,619) $ 491 $ 444,643 $ (13,868) $ 187,286 $ (892,818) $ 15,647
[1] Net income to the Company for the three and nine months ended September 26, 2021 excludes $692 and $2,192 allocable to the redeemable noncontrolling interests for our joint venture arrangements.
[2] Net income to the Company for the three and nine months ended September 25, 2022 excludes income of $31 and $559 allocable to the redeemable noncontrolling interests for our joint venture arrangements.